Hudson Bay Capital Management LP Coherus Bio Sciences, Inc. Transaction History

Hudson Bay Capital Management LP

$24.1 Billion
Q4 2024

A detailed history of Hudson Bay Capital Management LP transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 835,000 shares of CHRS stock, worth $893,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares

835,000

Previous 785,000 6.37%

Holding current value

$893,450

Previous $816,000 41.18%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.67 - $1.71 $33,500 - $85,500	50,000 Added 6.37%	835,000 $1.15 Million
Q2 2024 Aug 14, 2024	BUY	$1.58 - $2.51 $134,300 - $213,349	85,000 Added 12.14%	785,000 $1.36 Million
Q1 2024 May 15, 2024	BUY	$2.02 - $3.14 $232,300 - $361,100	115,000 Added 19.66%	700,000 $1.67 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $3.85 $278,250 - $673,750	175,000 Added 42.68%	585,000 $1.95 Million
Q3 2023 Nov 14, 2023	SELL	$3.74 - $5.45 $102,850 - $149,875	-27,500 Reduced 6.29%	410,000 $1.53 Million
Q2 2023 Aug 14, 2023	BUY	$3.79 - $8.3 $1.09 Million - $2.39 Million	287,500 Added 191.67%	437,500 $1.87 Million
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $853,500 - $1.51 Million	150,000 New	150,000 $1.19 Million
Q2 2022 Aug 12, 2022	BUY	$5.86 - $13.23 $908,300 - $2.05 Million	155,000 New	155,000 $1.12 Million
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $474,300 - $569,700	-30,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $697,400 - $978,450	-55,000 Reduced 64.71%	30,000 $482,000
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $97,125 - $115,575	-7,500 Reduced 8.11%	85,000 $1.18 Million
Q1 2021 May 14, 2021	BUY	$14.42 - $21.39 $1.33 Million - $1.98 Million	92,500 New	92,500 $1.35 Million
Q4 2020 Feb 12, 2021	SELL	$16.56 - $18.94 $745,200 - $852,300	-45,000 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$17.41 - $19.89 $435,250 - $497,250	-25,000 Reduced 35.71%	45,000 $825,000
Q2 2020 Aug 12, 2020	BUY	$14.43 - $19.16 $360,750 - $479,000	25,000 Added 55.56%	70,000 $1.25 Million
Q1 2020 May 14, 2020	BUY	$11.67 - $22.53 $54,382 - $104,989	4,660 Added 11.55%	45,000 $730,000
Q4 2019 Feb 12, 2020	BUY	$16.33 - $21.37 $658,752 - $862,065	40,340 New	40,340 $726,000
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $838,000 - $1.55 Million	-100,000 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$8.65 - $16.28 $865,000 - $1.63 Million	100,000 New	100,000 $905,000
Q2 2018 Aug 13, 2018	SELL	$10.25 - $17.45 $236,108 - $401,960	-23,035 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$9.1 - $13.7 $209,618 - $315,579	23,035 New	23,035 $255,000

Others Institutions Holding CHRS

# of Institutions

130

Shares Held

67.8M

Call Options Held

1.68M

Put Options Held

91.8K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $83.2M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Coherus Bio Sciences, Inc. Transaction History